Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
01/16/2002 | EP1086089B1 Method for producing butyrolactones |
01/16/2002 | EP0906300B1 Process for making phenyl heterocycles useful as cox-2 inhibitors |
01/16/2002 | EP0790246B1 Potentiator for nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
01/16/2002 | CN1331686A Method for prepn. of 5-cyanophthalide |
01/16/2002 | CN1331685A Method for preph. of citalopram |
01/15/2002 | US6339163 Adding hydroxymethylated derivative of tetrahydrofuran with ethylene oxide, and other epoxidized compounds to gasoline |
01/15/2002 | US6339161 Used in addition polymerization as polymerization catalyst |
01/15/2002 | US6339092 Metalloprotease inhibitors |
01/15/2002 | US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis |
01/15/2002 | US6339080 Iron compounds, compositions, methods of making the same and uses thereof |
01/10/2002 | WO2002002566A1 Therapeutic compounds and methods |
01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002508A1 Process for the preparation of substituted octanoyl amides |
01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
01/10/2002 | WO2002002111A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
01/10/2002 | WO2002002109A1 Use of galiella lactone |
01/10/2002 | US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
01/10/2002 | US20020004604 Antidepressant; alkylation of chemical intermediate |
01/10/2002 | DE10030646A1 Indigo-Derivate Indigo derivatives |
01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
01/10/2002 | CA2414660A1 Use of galiella lactone |
01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
01/09/2002 | EP1170296A2 Process for the preparation of 3-aryl-benzofuran-2-ones |
01/09/2002 | EP1170295A1 Thiocarbonates as flavour precursors |
01/09/2002 | EP1169314A1 Crystalline base of citalopram |
01/09/2002 | EP1169293A1 Liquid crystal compounds |
01/09/2002 | EP1169031A1 Antimicrobial agents |
01/09/2002 | EP1119558A4 Continuous process for the production of anhydrosugar alcohols |
01/09/2002 | EP0863886B1 Fluoromethoxyacrylic acid derivatives and their use as pest control agents |
01/09/2002 | EP0665859B1 Polymerization of cyclic ethers using selected metal compound catalysts |
01/09/2002 | CN1330571A Reactor module with contact tube bundle |
01/09/2002 | CN1330070A Perfume parent |
01/09/2002 | CN1330069A Substituted 2-benzo [c] furanone compound, its preparing process and medicinal composition containing it |
01/09/2002 | CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect |
01/09/2002 | CN1077563C Process for preparation of citraconic anhydride |
01/08/2002 | US6337401 Fluoromethoxyacrylic acid derivatives and their use as pest control agents |
01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
01/08/2002 | US6337347 Enhance gene expression in a wide variety of microorganisms, therapeutic compositions and therapeutic methods wherein gene expression within microorganisms is regulated are disclosed. |
01/08/2002 | US6337306 Herbicides for agriculture |
01/08/2002 | CA2120874E Form of form 1 ranitidine |
01/08/2002 | CA2019622C Substituted arylamines and heteroarylamines, their preparation process and pharmaceutical composition containing them |
01/03/2002 | WO2002000639A1 Synthesis of cyclic compounds |
01/03/2002 | WO2002000638A2 Substituted phthalides as anti-convulsive drugs |
01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
01/03/2002 | WO2002000606A1 Biphenyl compound |
01/03/2002 | WO2002000602A1 Benzophenones and sulfones as inhibitors of glycine uptake |
01/03/2002 | WO2002000180A2 Agents for colouring keratin fibres, containing derivatives of benzo[b]furane-3-one and/or benzo[b]thiophene-3-one |
01/03/2002 | WO2001070693A3 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
01/03/2002 | US20020002289 Method for producing carbonyl compound by dehydrogenating alcohol |
01/03/2002 | US20020002284 Processes and novel intermediates for 11-oxa prostaglandin synthesis |
01/03/2002 | US20020002187 Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin-resistance and hyperglycemia |
01/03/2002 | US20020002177 Endothelin receptor antagonists |
01/03/2002 | US20020002168 Heterocyclic carboxamides |
01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
01/03/2002 | US20020002150 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
01/03/2002 | CA2413752A1 Substituted phthalides as anti-convulsive drugs |
01/03/2002 | CA2413336A1 Synthesis of cyclic compounds |
01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
01/02/2002 | EP1167362A1 Fragance precursors |
01/02/2002 | EP1167361A2 Process and catalyst for the production of y-butyrolactones |
01/02/2002 | EP1165721A2 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring |
01/02/2002 | EP1165580A1 Catalytic method for modifying carbohydrates, alcohols, aldehydes or polyhydroxy compounds |
01/02/2002 | EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
01/02/2002 | EP1165539A1 Method of preparing benzofurandione oxime derivatives |
01/02/2002 | EP1165538A2 Process for the preparation of alpha-methylenelactones and alpha-substituted hydrocarbylidene lactones |
01/02/2002 | EP1165537A1 Hydroxymatairesinol in cancer prevention |
01/02/2002 | EP1165536A2 Process for the preparation of alpha-methylene lactones |
01/02/2002 | EP1165534A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
01/02/2002 | EP1165533A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
01/02/2002 | EP1165072A2 Valdecoxib compositions |
01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
01/02/2002 | EP1164846A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
01/02/2002 | EP0929560B1 Chiral ferrocenyls |
01/02/2002 | EP0745074B1 4-amino derivatives of mycophenolic acid with immunosuppressant activity |
01/02/2002 | CN1329608A Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenediamine group |
01/02/2002 | CN1329607A Substituted benzopyran analogs for treatment of inflammation |
01/02/2002 | CN1329605A Benzofuran derivatives their preparation and use |
01/02/2002 | CN1329000A Method for producing gamma-butyrolatone and catalyst |
01/02/2002 | CN1328824A Compound for curing female sexual disorder |
01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
01/01/2002 | US6335455 Process for the production of 2,5-dihydrofuran |
01/01/2002 | US6335454 Process for preparing 3-(1-hydroxphenyl-1-alkoximinomethyl)dioxazines |
01/01/2002 | US6335367 Fungicidal and insecticidal benzyloxy cyclopropyl substituted aromatic compounds |
01/01/2002 | US6335364 Tubulin polymerization inhibitors; antiproliferative and antitumor agents |
01/01/2002 | US6335345 Spiro compounds |
01/01/2002 | CA2186337C New amino 5,6,7,8-tetrahydronaphtho¬2,3-b|furane and indano¬5,6-b|furane derivatives; process for preparing the same and pharmaceutical compositions containing them |